menu
    • menu

    Company profile for WPD Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    WPD has 8 novel drug candidates with 4 that are in clinical development stage and 4 in pre-clinical development. These drug candidates were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland. Alongside direct investment of $60 million, over $29 million of g...
    WPD has 8 novel drug candidates with 4 that are in clinical development stage and 4 in pre-clinical development. These drug candidates were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland. Alongside direct investment of $60 million, over $29 million of grant funding (total of $89 million USD) has gone towards the development of our robust drug development pipeline with a focus on melanoma, brain cancer, leukemia and pancreatic cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    WPD PharmaceuticalsPoland Flag
    Country
    Country
    Poland
    Address
    Address
    Żwirki i Wigury 101, 02-089 Warszawa, Polska NIP: 5252721500, KRS: 0000693186
    Telephone
    Telephone
    +48 515 262 381
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://wpdpharmaceuticals.eu/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/wpd-management
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mabion & WPD Pharma Collaborate on WPD-401 Analytical Methods
    Mabion & WPD Pharma Collaborate on WPD-401 Analytical Methods

    18 Apr 2025

    // PRESS RELEASE

    https://www.mabion.eu/wp-content/uploads/2025/04/Mabion-and-WPD-Pharmaceuticals-Initiate-Collaboration-on-Analytical-Method-Development-for-WPD-401-press-release.pdf

    PRESS RELEASE
    18 Apr 2025
    Share Share
    WPD to Receive $6.7 M Grant for Development of Annamycin Drug Candidate
    WPD to Receive $6.7 M Grant for Development of Annamycin Drug Candidate

    11 May 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/05/11/2227066/0/en/WPD-Pharmaceuticals-to-Receive-6-7-Million-Grant-for-Development-of-Annamycin-Drug-Candidate.html#:~:text=(CSE%3A%20WBIO)(FSE%3A,of%20Annamycin%2C%20the%20Company's%20drug

    GLOBENEWSWIRE
    11 May 2021
    Share Share
    WPD to Attend the 10th Congress of the Polish Society of Pediatric Oncology
    WPD to Attend the 10th Congress of the Polish Society of Pediatric Oncology

    27 Apr 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/04/27/2217556/0/en/WPD-Pharmaceuticals-to-Attend-the-10th-Congress-of-the-Polish-Society-of-Pediatric-Oncology-and-Hematology-and-Present-Assumption-of-the-Phase-1-Study-with-Berubicin-in-Pediatric-M.html

    GLOBENEWSWIRE
    27 Apr 2021
    Share Share
    WPD Pharmaceuticals Announces Amended Sublicense Agreement with Moleculin
    WPD Pharmaceuticals Announces Amended Sublicense Agreement with Moleculin

    30 Mar 2021

    // GLOBENEWSWIRE

    http://www.globenewswire.com/news-release/2021/03/30/2201457/0/en/WPD-Pharmaceuticals-Announces-Amended-Sublicense-Agreement-with-Moleculin-Biotech-for-WP1066-WP1122-and-Annamycin-Drug-Candidates.html?f=22&fvtc=5&fvtv=32375057#:~:text=On%20March%2022%2C%202021%2C%20WPD,derived%20from%20these%20portfolios%20in

    GLOBENEWSWIRE
    30 Mar 2021
    Share Share
    WPD and CNS Announce Positive Opinion of the Polish Central WPD-201
    WPD and CNS Announce Positive Opinion of the Polish Central WPD-201

    18 Feb 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/02/18/2178169/0/en/WPD-and-CNS-Pharmaceuticals-Announce-Positive-Opinion-of-the-Polish-Central-Ethics-Committee-for-the-WPD-201-Study-and-Central-IRB-Study-Level-Approval-for-the-CNS-201-Study.html

    GLOBENEWSWIRE
    18 Feb 2021
    Share Share
    WPD Enters into Collaborative Agreement for WP1122, Receives Supply
    WPD Enters into Collaborative Agreement for WP1122, Receives Supply

    17 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/17/2079327/0/en/WPD-Pharmaceuticals-Enters-into-Collaborative-Agreement-for-WP1122-Receives-Supply-and-Appoints-New-CFO.html

    GLOBENEWSWIRE
    17 Aug 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search